1Herr HW, Shipley WU, Bajorin DF. Cancer of the Bladder. In: Cancer,Principles & Practice of Oncology.6th ed. DeVita VT, Hellman S,Rosenberg SA eds. Philadelphia: Lippincott Williams & Wilkins, 2001: 1396 -1418.
2Lomsso V, Pollera CF, Antimi M, et al. A phase Ⅱ study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Eur J Cancer, 1998,34:1208- 1212.
3Gebbia V, Testa A, Borsellino N, et al. Single - agent 2', 2' - difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase Ⅱ study. Clin Ter, 150(1): 11 - 15.
4Stadler WM, Kuzel T, Roth B, et al. Phase Ⅱ study of single - agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Gin Oncol, 1997,15:3394 - 3398.
5Moore MJ, Tannock IF, Ernst DS, et al. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol, 1997,15: 3441 - 3445.
6Marenco D, Castagneto B,Zai S, et al. Gemcitabine monochemotherapy in the elderly patient with advanced bladder cancer. Proc Annu Meet Am Soc Clin Onco 2002,21:A2414.
7von der Maase H, Andersen L, Crino L, et al. Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: a phase Ⅱ clinical trial. Ann Oncol, 1999, 10:1461 -1465.
8Moore MJ, Winquist EW, Murray N, et al. Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase Ⅱ trial of the National Cancer Institute of Canada Clinical Trials Group. J Glin Oncol,1999,17:2876 - 2881.
9Lippert C, Wechsel H, Koser M, Mueller D. Gemcitabine and cisplatinum in the treatment of stage Ⅳ bladder cancer - preliminary results of a Phase Ⅱ study with the 21 day-regimen. Eur Urol,2001,39(Suppl 5):141.
10Adamo V, D' Angelo A, Ferraro G, et al. C emcitabine(GEM) and cisplatin(Cis) in advanced/metastatic transitional cell carcinoma(TCC) of bladder: phase Ⅱ study. Ann Oncol, 2000,11 ( suppl 4): 79.
